Victory Capital Management’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$349K Buy
4,828
+138
+3% +$10.7K ﹤0.01% 2188
2026
Q2
$322K Sell
4,690
-58,815
-93% -$3.34M ﹤0.01% 2154
2026
Q1
$4.08M Buy
63,505
+36,530
+135% +$3.33M ﹤0.01% 1388
2025
Q4
$3.51M Sell
26,975
-49,157
-65% -$6.75M ﹤0.01% 1429
2025
Q3
$8.2M Buy
76,132
+51,347
+207% +$5.59M ﹤0.01% 1174
2025
Q2
$2.29M Buy
24,785
+9,120
+58% +$716K ﹤0.01% 1549
2025
Q1
$1.39M Buy
15,665
+12,945
+476% +$1.12M ﹤0.01% 1655
2024
Q4
$209K Buy
+2,720
New +$190K ﹤0.01% 2222
2023
Q3
– Sell
-11,617
Closed -$69.2K – 2561
2023
Q2
$69.2K Buy
11,617
+1,238
+12% +$9.8K ﹤0.01% 2352
2023
Q1
$125K Buy
10,379
+9,816
+1,744% +$131K ﹤0.01% 2327
2022
Q4
$4.9K Hold
563
– – ﹤0.01% 2567
2022
Q3
$16K Sell
563
-449
-44% -$20.6K ﹤0.01% 2640
2022
Q2
$42K Buy
1,012
+357
+55% +$24.2K ﹤0.01% 2566
2022
Q1
$46K Buy
655
+315
+93% +$35K ﹤0.01% 2602
2021
Q4
$50K Sell
340
-9
-3% -$2.01K ﹤0.01% 2642
2021
Q3
$88K Buy
+349
New +$120K ﹤0.01% 2631

Other funds holding WGS

Victory Capital Management's WGS Position: Q3 2026 in Review

Victory Capital Management increased its GeneDx Holdings (WGS) stake by 2.9% in Q3 2026, buying an estimated $10.7K and bringing the position to 4,828 shares worth $349K. The position accounts for ﹤0.01% of the portfolio, ranked #2188.

Victory Capital Management first reported a position in WGS in Q3 2021 and has held it in 16 quarters since. The position peaked at $8.2M in Q3 2025. 219 funds tracked by Wall St. Rank hold WGS as of Q3 2026.

  • Victory Capital Management held 4,828 shares of GeneDx Holdings worth $349K as of Q3 2026.
  • Victory Capital Management bought 138 GeneDx Holdings shares in Q3 2026, an estimated $10.7K.
  • GeneDx Holdings made up ﹤0.01% of Victory Capital Management's portfolio in Q3 2026, its #2188 holding.
  • Victory Capital Management first reported a position in GeneDx Holdings in Q3 2021 and has held it in 16 quarters since.
  • Victory Capital Management's GeneDx Holdings position peaked at $8.2M in Q3 2025.
  • 219 funds tracked by Wall St. Rank held GeneDx Holdings as of Q3 2026.

Based on Victory Capital Management's 13F filing for Q3 2026, filed 10 Nov 2026.